Journal Browser

Journal Browser

Nanoengineered Solutions: Advancements in Targeted Drug Delivery

A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Nanochemistry".

Deadline for manuscript submissions: 31 August 2024 | Viewed by 100

Special Issue Editor

E-Mail Website
Guest Editor
Department of Pharmaceutical Sciences & Nanomedicine Center of Excellence (COE), College of Pharmacy-Glendale, Midwestern University, Glendale, AZ, USA
Interests: nanomedicine; nutraceuticals; targeted delivery of therapeutics and contrasts; pharmaceutical formulations; cancer and cardiovascular pharmacotherapies
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

In recent years, the intersection between nanotechnology and medical science has given rise to transformative innovations. As defined by medical regulatory agencies, nanotechnology, i.e., controlling the shape and size of materials at the nanometer scale, can be used to create products with a nanomaterial in the finished dosage form, where a nanomedicine product is engineered to have properties with nanoscale dimensions. In the last few decades, we have witnessed the exponential growth of nanoscience biological and clinical applications, and scholarly attention has been drawn to one of the most promising areas of pharmaceutical research: “Nanomedicine and Nanobioengineering”.

Targeted drug delivery is key to revolutionizing therapeutic interventions. The ability to precisely direct therapeutic agents to specific sites within the body not only maximizes efficacy but also minimizes side effects. Nanoengineered solutions play a pivotal role in this paradigm shift towards patient-centred precision therapies, offering tailored approaches to drug delivery that promise breakthroughs not only in the diagnosis and treatment of a variety of pathological conditions, such as cardiovascular diseases, cancer, diabetes, immunological, inflammatory, and neurodegenerative disorders, but also offer protection against some of their genetic or epigenetic etiologies.

The fusion of nanotechnology and pharmaceuticals has unlocked unprecedented possibilities for enhancing the precision, physicochemical stability and efficiency, bioavailability, and safety of targeted nanodelivery systems.

We are pleased to invite you to contribute a paper for publication in this Special Issue titled “Nanoengineered Solutions”, which will serve as an open forum where researchers may share their current findings and expert opinions regarding this ever-growing area of research.

Thanks to the recent innovations in nanomedicine, the scope of this field has expanded to explore a diverse range of topics within the realm of nanoengineered targeted drug delivery systems. Areas of interest include, but are not limited to, innovative nanocarrier technologies, site (cellular and intracellular)-specific delivery, hybrid nanoplatforms, and nanocomposite (organic and inorganic/metalloid) nano-platforms.

This Special Issue will explore various routes of administration, i.e., both conventional (parenteral, topical, and oral) and unconventional (e.g., mucosal and ocular delivery, combination/coated medical devices, implants, and wearables) routes of administration, which can also be used for drug delivery and theranostic applications.

Here, we invite scholars and academic investigators to contribute their valuable insights and novel research, both in the form of original research and review article submissions, regarding the various roles of “Nanoengineered Solutions in Targeted Drug Delivery”. This Special Issue will help to explain their unique properties and demonstrate their specific clinical advantages and prospects for the development of pharmaceutical products.

Prof. Dr. Tamer Elbayoumi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • nanoscale engineering
  • nanomedicine
  • disease prevention and treatment
  • precision/targeted nanodelivery platforms/systems/formulations
  • targeted nanotheranostic applications
  • physicochemical characterization
  • bioavailability
  • pharmacodynamics
  • localized and systemic administration
  • safety and efficacy

Published Papers

This special issue is now open for submission.
Back to TopTop